(¿Â¶óÀÎ&¿ÀÇÁ¶óÀκ´Çà) Á¦20ȸ 2020³âµµ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2020-12-15±³À°ÀÏÀÚ : 2020-12-15
±³À°Àå¼Ò : ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL),
https://www.simd.or.kr/ ±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀκ´Çà) Á¦20ȸ 2020³âµµ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ
´ã´çÀÚ : ±èÈ£Á¤
¿¬¶ôó : 055-910-2187
À̸ÞÀÏ :
ksimd2014@naver.com ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í »çÀüµî·Ï(ȸ ¿ø): Àü¹®ÀÇ 4¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 3¸¸¿ø, ±âŸ 4¸¸¿ø »çÀüµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 6¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 5¸¸¿ø, ±âŸ 6¸¸¿ø ÇöÀåµî·Ï(ȸ ¿ø): Àü¹®ÀÇ 5¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 4¸¸¿ø, ±âŸ 5¸¸¿ø ÇöÀåµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 7¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 6¸¸¿ø, ±âŸ 7¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 10:00~10:30 Development of plant-based recombinant protein production technology to produce recombinant enzymes for LSD ȲÀÎȯ(Æ÷Ç×°ø´ë)
±³À°½Ã°£ 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 10:30~11:00 Treatment of LSD using approach through intra ventricular replacement of recombinant enzymes in human and animal models; Novel approach to prevent deterioration of the CNS Áøµ¿±Ô(¼º±Õ°üÀÇ´ë)
Åä·Ð 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 11:00~12:00 oral presentation ()
½Ä»ç 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 12:00~13:00 ½Ä»ç ()
±³À°½Ã°£ 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 13:00~13:30 Development of animal models for rare disease & gene therapy for GM1 gangliosidosis ±èÇö¾Æ(³ì½ÊÀÚ·¦¼¿)
±³À°½Ã°£ 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 13:30~14:00 Characterization of the subventricular-thalamo-cortical circuit in the Niemann-Pick type C mouse brain, and new insights regarding treatment ÁøÈñ°æ(°æºÏ¼öÀÇ´ë)
±³À°½Ã°£ 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 14:00~14:30 Escape from the maze ÀÌÁø¼º(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 14:30~14:50 Coffee break & e-poster rounding ()
Åä·Ð 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 14:50~15:50 oral presentation ()
±³À°½Ã°£ 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 15:50~16:20 Long-term management of PKU; what have we learnt? ÀÌÁ¤È£(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 16:20~16:50 Long-term consequences of lysosomal storage disease ¼Õ¿µ¹è(¾ÆÁÖÀÇ´ë)
ÈÞ½Ä 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 16:50~17:05 ()
±³À°½Ã°£ 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 17:05~17:35 IMD cases diagnosed by next-generation sequencing À̹üÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 12¿ù 15ÀÏ ÀÎÅÍÄÜƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ¾Ë·¹±×·Î·ë(HL) 17:35~18:05 Nutritional therapy of IMD: goals and challenges À±¼öÁø(¼øõÇ⼿ﺴ¿ø)